ALLI
NDC 0135-0461, orlistat, capsule, from Haleon US Holdings LLC.
- Product NDC
- 0135-0461
- Status
- Listed
- Labeler
- Haleon US Holdings LLC
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- NDA
- Application
- NDA021887
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0135-0461 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ORLISTAT60 mg/1
Pharmacologic classes
Intestinal Lipase Inhibitor [EPC]; Lipase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0135-0461-01 | 00135046101 | 60 CAPSULE in 1 BOTTLE (0135-0461-01) |
| 0135-0461-05 | 00135046105 | 120 CAPSULE in 1 BOTTLE (0135-0461-05) |
| 0135-0461-06 | 00135046106 | 170 CAPSULE in 1 BOTTLE (0135-0461-06) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 0135-0461 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0135-0461 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0135-0461. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.